Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study

BACKGROUND: Prior studies regarding use of Aromatase inhibitors (AIs) and risk for cardiovascular disease (CVD) have shown conflicting results. This retrospective cohort study aimed to investigate whether AIs use affects risk for CVD events in postmenopausal breast cancer survivors. METHODS: Using a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sund, Maria, Garcia-Argibay, Miguel, Garmo, Hans, Ahlgren, Johan, Wennstig, Anna-Karin, Fredriksson, Irma, Lindman, Henrik, Valachis, Antonis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281646/
https://www.ncbi.nlm.nih.gov/pubmed/34265496
http://dx.doi.org/10.1016/j.breast.2021.07.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281646/
https://www.ncbi.nlm.nih.gov/pubmed/34265496
http://dx.doi.org/10.1016/j.breast.2021.07.004

Ejemplares similares